American Society of Clinical Oncology Honors Wilmot Physician with National Award
Supriya G. Mohile, M.D., M.S., an oncologist at the Wilmot Cancer Institute and trailblazer in the growing field of geriatric oncology, has been named the 2018 winner of the B.J. Kennedy Award by the American Society of Clinical Oncology (ASCO). She will deliver the B.J. Kennedy Lecture on June 4 at ASCO ’s annual meeting in Chicago. (Source: University of Rochester Medical Center Press Releases)
Source: University of Rochester Medical Center Press Releases - May 23, 2018 Category: Universities & Medical Training Authors: University of Rochester Medical Center Source Type: news

J & J hit with $21.7 million verdict in another talc asbestos cancer case
NEW YORK (Reuters) - Johnson& Johnson and its talc suppliers on Wednesday were hit with a $21.7 million jury verdict in a lawsuit by a woman who said she developed cancer after being exposed to asbestos in the company's Baby Powder. (Source: Reuters: Health)
Source: Reuters: Health - May 23, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Disturbing lung cancer trend among young women
Lung cancer has long been associated mostly with men. But a new study finds a disturbing trend among women, even among those who do not smoke. Tara Narula reports. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - May 23, 2018 Category: Consumer Health News Source Type: news

Obesity may make women more vulnerable to a host of cancers, especially if they gain weight quickly
Compared to women of normal weight, those with obesity are 24% more likely to develop one of a handful of cancers linked to the condition, and their chances of developing cancers of the kidney or endometrium were around twice as high as those of normal-weight women, new research has found.In a... (Source: Los Angeles Times - Science)
Source: Los Angeles Times - Science - May 23, 2018 Category: Science Authors: Melissa Healy Source Type: news

Lung Cancer Rate Now Rising Faster in Young Women
In general, the study found, the incidence of the disease dipped over time. But men saw a sharper decrease, so that the traditional male-female pattern flipped. (Source: WebMD Health)
Source: WebMD Health - May 23, 2018 Category: Consumer Health News Source Type: news

The ten-point plan that cuts the risk of cancer by 40 per cent
In the biggest analysis of its kind, experts warn junk food, ready meals and red meat should be eaten only in moderation in favour of a diet that is rich in wholegrains, fruit and vegetables. (Source: the Mail online | Health)
Source: the Mail online | Health - May 23, 2018 Category: Consumer Health News Source Type: news

New concerns about lung cancer risk in young women
Researchers aren't sure why lung cancer incidence rates in women age 30 to 54 aren't falling as fast as in men the same age. CBS News' Meg Oliver reports. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - May 23, 2018 Category: Consumer Health News Source Type: news

WCRF Blueprint for Lifestyle Changes to Prevent Cancer WCRF Blueprint for Lifestyle Changes to Prevent Cancer
A new report that reviews all the data from the last 30 years on diet, weight, physical activity, and cancer has come up with practical guidelines on lifestyle changes.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 23, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Weight-loss surgery reduces the risk of deadly skin cancer by more than 60%, study finds  
Researchers from the University of Gothenburg found that people who have a gastric band or bypass are 61 per cent less likely to develop melanoma, which can spread to other organs. (Source: the Mail online | Health)
Source: the Mail online | Health - May 23, 2018 Category: Consumer Health News Source Type: news

Cinnamon - Flavored E - Cigs May Bring Lung Dangers: Study
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - May 23, 2018 Category: Cancer & Oncology Tags: Oncology, Research, Preventive Medicine, News, Source Type: news

Blaze Bioscience aims to launch new pediatric brain cancer study with scorpion venom
Blaze Bioscience has scooped up $4 million of a $5 million round to maintain its momentum to hopefully initiate a Pivotal clinical study on pediatric brain cancer later this year. Blaze is the company behind Tumor Paint, a synthetic scorpion venom that binds to cancer cells and glows under near-infrared light. The Puget Sound Business Journal featured Blaze last year as an Innovator of the Month. At the time, the company had raised $30 million since its founding, and Tum or Paint had been used… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 23, 2018 Category: Biotechnology Authors: Coral Garnick Source Type: news

Blaze Bioscience aims to launch new pediatric brain cancer study with scorpion venom
Blaze Bioscience has scooped up $4 million of a $5 million round to maintain its momentum to hopefully initiate a Pivotal clinical study on pediatric brain cancer later this year. Blaze is the company behind Tumor Paint, a synthetic scorpion venom that binds to cancer cells and glows under near-infrared light. The Puget Sound Business Journal featured Blaze last year as an Innovator of the Month. At the time, the company had raised $30 million since its founding, and Tum or Paint had been used… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - May 23, 2018 Category: Health Management Authors: Coral Garnick Source Type: news

Troubling lung cancer trend in young women
New research reveals a shift in lung cancer rates among younger Americans (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - May 23, 2018 Category: Consumer Health News Source Type: news

Grail Brings VC Funding to $1.5B with Latest Round
Even two years after its inception, Grail is still continuing to bring in huge financing rounds. This time, the liquid biopsy specialist raised $300 million in its oversubscribed Series C round. The Menlo Park, CA now has raised $1.5 billion in its pursuit to develop the holy grail of cancer detection tests. The financing is led by Ally Bridge Group, co-led by Hillhouse Capital Group and 6 Dimensions Capital, and includes Blue Pool Capital, China Merchant Securities International, CRF Investment, HuangPu River Capital (HPR), ICBC International, Sequoia Capital China, and WuXi NextCODE. Grail said the Series C funding will ...
Source: MDDI - May 23, 2018 Category: Medical Devices Authors: Omar Ford Tags: IVD Source Type: news

Sun Pharma Announces FDA Approval of Yonsa (abiraterone acetate) to Treat Metastatic Castration-Resistant Prostate Cancer
MUMBAI& PRINCETON, N.J.& KING OF PRUSSIA, Pa. May 23, 2018 --(BUSINESS WIRE)--Sun Pharmaceutical Industries Ltd. and includes its subsidiaries and/or associate companies) and Churchill Pharmaceuticals, LLC. (Churchill) today announced that... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - May 23, 2018 Category: Drugs & Pharmacology Source Type: news

FDA Warns About Pills That Claim To Protect You From Sun
BOSTON (CBS) – The FDA is sending warning letters to four dietary supplement makers that are marketing tablets and capsules claiming to be a substitute for sunscreen. Skin cancer is the most common cancer in the united states and there’s a direct link between skin cancer and exposure to UV light. The FDA says some companies are misleading consumers by claiming that taking a daily supplement will offer protection against sun damage. The Agency says there is no credible science to back up their claims and these companies are giving people a false sense of security. (Source: WBZ-TV - Breaking News, Weather and Sp...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - May 23, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Syndicated Local Dr. Mallika Marshall FDA Sunscreen Source Type: news

Lung cancer rates in younger white and Hispanic women surpass those of men
Reversing a historic trend, rates of lung cancer among younger white and Hispanic women have surpassed those of men — and the change cannot be fully explained by gender differences in smoking behavior, researchers said Wednesday. Previous research pointed to shifts in the incidence of lung cancer, with rates creeping up among some groups of […]Related:More men with low-risk prostate cancer are forgoing aggressive treatmentThirdhand smoke is widespread and may be dangerous, mounting evidence showsFDA cracks down on sales of Juul, other e-cigarettes to youths (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - May 23, 2018 Category: Consumer Health News Source Type: news

Cancer Deaths Rates Drop Overall, but Not All Types
(MedPage Today) -- Annual report also finds increase in distant-stage prostate cancer (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - May 23, 2018 Category: Hematology Source Type: news

Pulmonx touts quality of life, lung function improvements in 1-year Zephyr endobronchial valve IDE study
This study was the largest, longest study to use a less-invasive or minimally-invasive technique using these one-way valves,” Dr. Criner said. Dr. Criner said that after one year, patients treated with the Zephyr valves were significnatly more likely to show improvements in lung function, measured as forced expiratory volume in one second, or FEV1. “Patients that were treated had about a three times greater likelihood of having significant improvement in FEV1, more than 15% in 45% of the treated group compared to 11% of the control,” Dr. Criner said. Additionally, patients treated with the Zephyr reported...
Source: Mass Device - May 23, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Respiratory Pulmonx Source Type: news

Amgen Enters Groundbreaking Collaboration To Improve Symptom Management During Cancer Treatment
Public-Private Partnership Aims to Connect Underserved Cancer Patients to Enhanced Symptom Management Support Through the Use of Connected Technologies THOUSAND OAKS, Calif., May 23, 2018 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced a groundbreaking collaboration with the National Cancer Institute (NCI), the Federal Communications Commission (FCC) Connect2Health Task Force, the University of Kentucky (UK) Markey Cancer Center and the University of California, San Diego (UCSD) Design Lab to support the improvement of cancer outcomes. The L.A.U.N.C.H. (Linking & Amplifying User-Centered Networks through ...
Source: Amgen News Release - May 23, 2018 Category: Pharmaceuticals Tags: Uncategorized Source Type: news

MEAL: Men Changed Diet but Not Prostate Cancer Progression MEAL: Men Changed Diet but Not Prostate Cancer Progression
In a trial that was both a triumph and a disappointment, increasing intake of vegetables had no effect on disease progression for men with prostate cancer.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 23, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Capital Digestive Care buys medical office complex in Rockville
Capital Digestive Care LLC, a Silver Spring-based gastroenterology group, has purchased a 100,000-square-foot space in Rockville. Terms of the deal were not disclosed in a release sent out Wednesday. The medical office complex includes two properties at 15001 and 15005 Shady Grove Road in Rockville, where an existing tenant already holds a 35,000-square-foot master lease. It’s situated within Montgomery County’s Life S ciences Corridor near Shady Grove Adventist Hospital, the National Cancer… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 23, 2018 Category: American Health Authors: Sara Gilgore Source Type: news

Active Surveillance for Low-Risk Thyroid Cancer: Lessons From Japan Active Surveillance for Low-Risk Thyroid Cancer: Lessons From Japan
Physicians at hospital in Japan detail how active surveillance of low-risk papillary thyroid microcarcinomas has evolved, hoping to encourage other countries that have been slower to adopt the approach.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 23, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Pancreatic cancer symptoms: Three early signs that could indicate you have the disease
PANCREATIC cancer symptoms usually don ’t show in the early stages, which can make it difficult to diagnose. If they do show, there are three early signs to be aware of. But to avoid the disease completely, it’s important to know what the causes of this type of cancer are. (Source: Daily Express - Health)
Source: Daily Express - Health - May 23, 2018 Category: Consumer Health News Source Type: news

Lung Cancer Incidence Higher for Young Women Than Young Men
WEDNESDAY, May 23, 2018 -- Lung cancer incidence is higher among young women than young men, according to a study published in the May 24 issue of the New England Journal of Medicine. Ahmedin Jemal, D.V.M., Ph.D., from the American Cancer Society in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 23, 2018 Category: Pharmaceuticals Source Type: news

Medical News Today: Can BPH cause kidney failure?
Benign prostatic hyperplasia (BPH) refers to enlargement of the prostate that is unrelated to cancer. Because of the positions of the prostate and kidneys, an enlarged prostate can cause kidney, or renal, failure. Knowing the symptoms can ensure quick treatment. Learn about the links between renal failure and BPH here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 23, 2018 Category: Consumer Health News Tags: Prostate / Prostate Cancer Source Type: news

Oral, Gastric Bugs May Help Pinpoint Stomach Cancer
(MedPage Today) -- Negative changes in microbe composition, interaction tied to gastric carcinogenesis stages (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - May 23, 2018 Category: Hematology Source Type: news

PSA-screening Rates Down After 2012 Task-force Recommendations PSA-screening Rates Down After 2012 Task-force Recommendations
Prostate-specific antigen (PSA) screening for prostate cancer declined after the U.S. Preventive Services Task Force (USPSTF) advised against it in 2012, researchers have found.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 23, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Palliative Care Training Helps Doctors Steer Cancer Patients Away From Major Surgery Palliative Care Training Helps Doctors Steer Cancer Patients Away From Major Surgery
Doctors who don't have palliative care training are more likely to recommend aggressive surgery for patients with life-limiting diseases, a study suggests.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 23, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Lung Cancer Rate Now Higher in Young Women Than Young Men
WEDNESDAY, May 23, 2018 -- In a reversal of historical patterns, lung cancer is now more common among young U.S. women than men, a new study finds. The good news, researchers found, is that over the past two decades, lung cancer rates among 35- to... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 23, 2018 Category: General Medicine Source Type: news

Cryoablation Efficacious for Cancer Pain, Review Finds
Cryoablation also cuts the need for opioids at 24 hours post - treatment and at three months (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - May 23, 2018 Category: Cancer & Oncology Tags: Oncology, Anesthesiology & amp; Pain, Journal, Source Type: news

Mother and daughter with breast cancer have both been given the all clear
Lucy Eardley, 37, from Macclesfield, Cheshire, discovered she had the disease in July 2016, with her mother Angela Bucknell, 64, receiving the same diagnosis eight weeks later. (Source: the Mail online | Health)
Source: the Mail online | Health - May 23, 2018 Category: Consumer Health News Source Type: news

Merck's cancer drug Keytruda notches another trial success
(Reuters) - Merck& Co said on Wednesday its drug Keytruda helped patients with a certain type of lung cancer live longer and prevented the disease from spreading, helping to solidify its position in the lucrative cancer market. (Source: Reuters: Health)
Source: Reuters: Health - May 23, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Bright-Light Rx May Help Alleviate Cancer-Related Fatigue Bright-Light Rx May Help Alleviate Cancer-Related Fatigue
Nonpharmacologic approaches, such as bright-light therapy, can help alleviate cancer-related fatigue, which affects almost all patients with cancer.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 23, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Patience Needed: WM Is Incurable, but Survival Is Long Patience Needed: WM Is Incurable, but Survival Is Long
Management of the rare lymphoma Waldenstrom's macroglobulinemia (WM) takes patience and practice to maximize longevity and keep symptoms at bay over the long haul.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 23, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Even standing close to a barbecue raises your cancer risk
Eating barbecued food and grill smoke that soaks into the skin exposes people to even higher levels of carcinogenic chemicals than inhaling the fumes does, according to a new Chinese study. (Source: the Mail online | Health)
Source: the Mail online | Health - May 23, 2018 Category: Consumer Health News Source Type: news

Skin May Absorb Toxins from Grill Fumes
Grilling meats at a high temperature can produce cancer-causing compounds called polycyclic aromatic hydrocarbons (PAHs). (Source: WebMD Health)
Source: WebMD Health - May 23, 2018 Category: Consumer Health News Source Type: news

What You Need To Know If You ’ve Just Been Diagnosed With Cancer
Don't be afraid to take control of your medical care — here's how to do it. (Source: Healthy Living - The Huffington Post)
Source: Healthy Living - The Huffington Post - May 23, 2018 Category: Consumer Health News Source Type: news

mAbxience and Amneal Enter Into an Agreement for Bevacizumab Biosimilar in the United States
The agreement to bring a biosimilar of bevacizumab to the United States will improve patient access and affordability of this important oncology treatment MADRID, May 23, 2018 -- (Healthcare Sales & Marketing Network) -- mAbxience, a company specialize... Biopharmaceuticals, Generics, Licensing mAbxience, Insud Pharma Group, Amneal Pharmaceuticals, bevacizumab, biosimilar (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 23, 2018 Category: Pharmaceuticals Source Type: news

Cancer Deaths Falling, but Uptick in Late-Stage Prostate Ca Cancer Deaths Falling, but Uptick in Late-Stage Prostate Ca
Overall, deaths from cancer in the US continue to decline, but there are two notable exceptions, and there has been an uptick in the incidence of late-stage prostate cancer.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 23, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

RenovoRx raises $7m for drug-device pancreatic cancer therapy
RenovoRx said today that it closed a $7 million tranche in a $10 million round to fund the development of its drug-device combination product designed to deliver chemotherapy directly to tumors in patients with locally advanced pancreatic cancer. The company’s round was led by Boston Scientific (NYSE:BSX) and joined by btov Partners, Astia Angels, Golden Seeds and others. Get the full story at our sister site, Drug Delivery Business News. The post RenovoRx raises $7m for drug-device pancreatic cancer therapy appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - May 23, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Food & Drug Administration (FDA) Funding Roundup Oncology Pharmaceuticals Regulatory/Compliance Vascular RenovoRx Source Type: news

Cryoablation Efficacious for Cancer Pain, Review Finds
WEDNESDAY, May 23, 2018 -- Cryoablation is effective for controlling cancer pain without many side effects, according to a review published online May 7 in PAIN Practice. Laura Ferrer-Mileo, from L'Hospitalet de Llobregat in Barcelona, Spain, and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 23, 2018 Category: Pharmaceuticals Source Type: news

Junk food ads cause UK teens to eat 18,000 extra calories a year, new research warns.
Teens who watch one extra junk food ad a week - over the average of six - eat an additional 350 calories in foods high in salt, sugar and fat every week, according to a study by Cancer Research UK. (Source: the Mail online | Health)
Source: the Mail online | Health - May 23, 2018 Category: Consumer Health News Source Type: news

The FDA Is Warning People to Steer Clear of Sunscreen Pills
Sunscreen comes in many forms, from lotions to sprays to creams — but the Food and Drug Administration (FDA) is warning consumers to steer clear of one formula in particular: so-called sunscreen pills. The agency on Tuesday announced that it sent warnings letters to four companies claiming to make dietary supplements that can protect people from sun damage, and reminded consumers that, “There’s no pill or capsule that can replace your sunscreen.” The announcement specifically calls out four products — GliSODin Skin Nutrients’ Advanced Skin Brightening Formula, Napa Valley Bioscience&rsqu...
Source: TIME: Health - May 23, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthytime onetime Supplements Source Type: news

Merck's Keytruda succeeds in late-stage lung cancer study
(Reuters) - Merck& Co on Wednesday said its cancer drug Keytruda helped extend survival and prevented disease progression when tested in a late-stage study in combination with chemotherapy for a type of lung cancer. (Source: Reuters: Health)
Source: Reuters: Health - May 23, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Study finds a weak handshake may predict an early death from cancer
Grip strength may be better than current methods to predict lifespan, heart attack risk, lung disease risk, and even cancer risk, a large study by the University of Glasgow suggests. (Source: the Mail online | Health)
Source: the Mail online | Health - May 23, 2018 Category: Consumer Health News Source Type: news

Former Gilead R & D chief to lead cancer drug startup in Cambridge
One month after stepping down as head of research and development at Gilead Sciences, Norbert Bischofberger has taken the helm of a new cancer drug startup in Cambridge. Kronos Bio formally announced its launch on Wednesday. The company is operating out of LabCentral, and has collected $18 million in seed financing from various venture funds and individual investors. They include Bischofberger, who spent more than 30 years with California-based Gilead (Nasdaq: GIL D) before leaving in April. Kronos’… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 23, 2018 Category: Pharmaceuticals Authors: Max Stendahl Source Type: news

UK Study Finds Late Diagnosis of Prostate Cancer a Worrisome Trend for UK ’s National Health Service
Pathologists around the world will be interested to learn that, for the first time in the UK, prostate cancer has surpassed breast cancer in numbers of deaths annually and nearly 40% of prostate cancer diagnoses occur in stages three and four Early detection of prostate cancer, and the ability to identify its more aggressive forms, […] (Source: Dark Daily)
Source: Dark Daily - May 23, 2018 Category: Laboratory Medicine Authors: Jude Tags: Digital Pathology Laboratory Management and Operations Laboratory News Laboratory Operations Laboratory Pathology Laboratory Testing breast cancer CDC centers for disease control and prevention clinical laboratory Dr. Ghulam Nabi Has Source Type: news

He helped Gilead score billions from HIV, hepatitis C drugs — now he's building a cancer fighter
Norbert Bischofberger rides again. The 62-year-old former chief scientific officer at Gilead Sciences Inc. (NASDAQ: GILD), who stepped down last month after overseeing the development of groundbreaking and sometimes-controversial HIV and hepatitis C drugs, will become president and CEO of Cambridge, Mass., cancer-fighting startup K ronos Bio Inc. And Bischofberger, an investor in Kronos' $18 million seed round disclosed Wednesday, isn't alone: Also investing in the company is Gilead's executive… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 23, 2018 Category: Biotechnology Authors: Ron Leuty Source Type: news

Former Gilead R & D chief to lead cancer drug startup in Cambridge
One month after stepping down as head of research and development at Gilead Sciences, Norbert Bischofberger has taken the helm of a new cancer drug startup in Cambridge. Kronos Bio formally announced its launch on Wednesday. The company is operating out of LabCentral, and has collected $18 million in seed financing from various venture funds and individual investors. They include Bischofberger, who spent more than 30 years with California-based Gilead (Nasdaq: GIL D) before leaving in April. Kronos’… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 23, 2018 Category: Biotechnology Authors: Max Stendahl Source Type: news